Federal Funding of Medical Countermeasures Opportunities Risks and Enforcement Trends

Bueker, J., Weinman, B., and McCarthy, J. (2022). Federal Funding of Medical Countermeasures: Opportunities, Risks, and Enforcement Trends. Food and Drug Law Institute (FDLI).
This webpage contains information on federal funding of medical countermeasures, including opportunities and risks of new wave funding and strategies to reduce risks. The authors conclude that federal funding for medical countermeasures has created opportunities for the life sciences industry, but that those risks also need to be mitigated with compliance infrastructure and steady supply contracts.
You must Login to add a comment
  • This item doesn't have any comments

Enter your email address to receive important announcements and updates through the ASPR TRACIE Listserv.